Drug development: Intelligent research management
by SAS Institute Inc.
This white paper by SAS Institute Inc. describes the problems faced by life sciences field companies that outsource their research information technology (IT) functions, and asserts that biomedical informatics represents a viable solution. It provides an overview of SAS's drug development strategy and its knowledge domain, which consists of data and information associated with the development of a biomedical product. SAS drug development has four major components: the collaborative framework; data warehousing; analysis and reporting, and regulatory submission support, facilitated through a browser-based interface.
| Published: | 2002 |
| Format: | |
| Length: | 12 pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
